• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CRIS

CRIS

Curis, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.50

-0.00 (-0.50%)

Rating:C-

Company Profile

CEO

James E. Dentzer

IPO Date

2000-08-01

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.51

Prev. Close

$0.50

Day Low

$0.50

Day High

$0.52

52W Low

$0.46

52W High

$3.13

Market Cap

$0.01B

Volume

0.17M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

23.8%

Avg Negative

12.6%

Avg Neutral

63.9%

News Feed

Curis Inc.: Revisiting CA-4948 After Q2 Update

Seeking Alpha·8/25/2021·↑ positive

Curis' (CRIS) CEO Jim Dentzer on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/3/2021·↓ negative

Curis (CRIS) Reports Q2 Loss, Lags Revenue Estimates

Zacks Investment Research·8/3/2021·↑ positive

Recap: Curis Q2 Earnings

Benzinga·8/3/2021·↑ positive

Curis Reports Second Quarter 2021 Financial Results

PRNewsWire·8/3/2021·↓ negative

Curis, Inc. Set to Join Russell 2000®, 3000® and Microcap® Indexes

PRNewsWire·6/25/2021·↑ positive

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Curis, Inc. - CRIS

PRNewsWire·6/16/2021·↓ negative

Curis' Plunge Is A Buying Opportunity

Seeking Alpha·6/13/2021·↓ negative

Why Curis Fell Off a Cliff on Friday

The Motley Fool·6/11/2021·↑ positive

Curis Shares Drop After Updated CA-4948 Data From Mid-Stage Blood Cancer Trial

Benzinga·6/11/2021·↑ positive